StockData
McKesson Corp logo

McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3027% above fair value
$1084.43−7.24 (-0.66%)

Close on Nov 18, 2026Market cap $126.43BP/E 29.0Yield 0.29%

McKesson revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

McKesson's revenue for the twelve months ending Jun 30, 2026 was $410.98B, up 8.8% year over year. For fiscal 2026 it was $403.43B, up 12.4% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $403.43B in fiscal 2026.

Annual revenue

PeriodPeriod endValueChange
FY2026Mar 31, 2026$403.43B+12.4%
FY2025Mar 31, 2025$359.05B+16.2%
FY2024Mar 31, 2024$308.95B+11.7%
FY2023Mar 31, 2023$276.71B+4.8%
FY2022Mar 31, 2022$263.97B+10.8%
FY2021Mar 31, 2021$238.23B+3.1%
FY2020Mar 31, 2020$231.05B+7.8%
FY2019Mar 31, 2019$214.32B+2.9%
FY2018Mar 31, 2018$208.36B+4.9%
FY2017Mar 31, 2017$198.53B+4.0%
FY2016Mar 31, 2016$190.88B+6.6%
FY2015Mar 31, 2015$179.05B+30.3%
FY2014Mar 31, 2014$137.39B+12.4%
FY2013Mar 31, 2013$122.20B-0.1%
FY2012Mar 31, 2012$122.32B+9.1%
FY2011Mar 31, 2011$112.08B+3.1%
FY2010Mar 31, 2010$108.70B+1.9%
FY2009Mar 31, 2009$106.63B+4.8%
FY2008Mar 31, 2008$101.70B–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026$105.38B+7.7%
Q4 FY2026CQ1 2026Mar 31, 2026$96.30B+6.0%
Q3 FY2026CQ4 2025Dec 31, 2025$106.16B+11.4%
Q2 FY2026CQ3 2025Sep 30, 2025$103.15B+10.1%
Q1 FY2026CQ2 2025Jun 30, 2025$97.83B+23.4%
Q4 FY2025CQ1 2025Mar 31, 2025$90.82B+18.9%
Q3 FY2025CQ4 2024Dec 31, 2024$95.29B+17.8%
Q2 FY2025CQ3 2024Sep 30, 2024$93.65B+21.3%
Q1 FY2025CQ2 2024Jun 30, 2024$79.28B+6.4%
Q4 FY2024CQ1 2024Mar 31, 2024$76.36B+10.8%
Q3 FY2024CQ4 2023Dec 31, 2023$80.90B+14.8%
Q2 FY2024CQ3 2023Sep 30, 2023$77.22B+10.1%
Q1 FY2024CQ2 2023Jun 30, 2023$74.48B+10.9%
Q4 FY2023CQ1 2023Mar 31, 2023$68.91B+4.2%
Q3 FY2023CQ4 2022Dec 31, 2022$70.49B+2.7%
Q2 FY2023CQ3 2022Sep 30, 2022$70.16B+5.4%
Q1 FY2023CQ2 2022Jun 30, 2022$67.15B+7.1%
Q4 FY2022CQ1 2022Mar 31, 2022$66.10B+11.8%
Q3 FY2022CQ4 2021Dec 31, 2021$68.61B+9.6%
Q2 FY2022CQ3 2021Sep 30, 2021$66.58B+9.5%
Q1 FY2022CQ2 2021Jun 30, 2021$62.67B+12.6%
Q4 FY2021CQ1 2021Mar 31, 2021$59.14B+1.0%
Q3 FY2021CQ4 2020Dec 31, 2020$62.60B+5.8%
Q2 FY2021CQ3 2020Sep 30, 2020$60.81B+5.5%
Q1 FY2021CQ2 2020Jun 30, 2020$55.68B-0.1%
Q4 FY2020CQ1 2020Mar 31, 2020$58.54B+11.6%
Q3 FY2020CQ4 2019Dec 31, 2019$59.17B+5.3%
Q2 FY2020CQ3 2019Sep 30, 2019$57.62B+8.6%
Q1 FY2020CQ2 2019Jun 30, 2019$55.73B+5.9%
Q4 FY2019CQ1 2019Mar 31, 2019$52.43B+1.6%
Q3 FY2019CQ4 2018Dec 31, 2018$56.21B+4.8%
Q2 FY2019CQ3 2018Sep 30, 2018$53.08B+1.9%
Q1 FY2019CQ2 2018Jun 30, 2018$52.61B+3.0%
Q4 FY2018CQ1 2018Mar 31, 2018$51.63B+6.0%
Q3 FY2018CQ4 2017Dec 31, 2017$53.62B+7.0%
Q2 FY2018CQ3 2017Sep 30, 2017$52.06B+4.2%
Q1 FY2018CQ2 2017Jun 30, 2017$51.05B–
Q4 FY2017CQ1 2017Mar 31, 2017$48.71B–
Q3 FY2017CQ4 2016Dec 31, 2016$50.13B–
Q2 FY2017CQ3 2016Sep 30, 2016$49.96B–

More McKesson figures

See a number that looks wrong?